Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors

Publication

dc.contributor.author	Chícharo, Ana Teodósio
dc.contributor.author	Lopes, Ana R.
dc.contributor.author	Barreira, Sofia
dc.contributor.author	Pinto, Luísa
dc.contributor.author	Machado, Ana R. Cruz
dc.contributor.author	Capela, Susana
dc.date.accessioned	2024-12-06T09:40:50Z
dc.date.available	2024-12-06T09:40:50Z
dc.date.issued	2024-01-01
dc.description.abstract	No safety or efficacy issues arose from using biosimilar TNFi during conception or pregnancy.	eng
dc.identifier.doi	10.1093/rap/rkae044
dc.identifier.issn	2514-1775
dc.identifier.uri	http://hdl.handle.net/10400.1/26402
dc.language.iso	eng
dc.peerreviewed	yes
dc.publisher	Oxford University Press
dc.relation.hasversion	https://academic.oup.com/rheumap/article/8/2/rkae044/7632095
dc.relation.ispartof	Rheumatology Advances in Practice
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.subject	Pregnancy
dc.subject	Rheumatic disorders
dc.subject	Mothers
dc.subject	Perinatal period
dc.subject	Tumor necrosis factor inhibitors
dc.subject	Biosimilar pharmaceuticals
dc.title	Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors	eng
dc.type	journal article
dspace.entity.type	Publication
oaire.citation.endPage	3
oaire.citation.issue	2
oaire.citation.startPage	1
oaire.citation.title	Rheumatology Advances in Practice
oaire.citation.volume	8
oaire.version	http://purl.org/coar/version/c_970fb48d4fbd8a85

Files

Now showing 1 - 1 of 1

Name:: Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors.pdf
Size:: 513.99 KB
Format:: Adobe Portable Document Format

Now showing 1 - 1 of 1